After 30 years, a protection provider finally removes a contentious sentence of small print from its term assurance policy writes Roger Edwards.
Munich Re's Mike Bolshaw discusses how developments in immunotherapy for cancer patients could impact terminal illness and life insurance claims.
In recent months I've heard discussions about whether or not insurers should scrap this benefit, which is typically included on most life insurance policies, writes Kevin Carr.